Soybean conglycinin combined have exerted distinct hypocholesterolemic effects

What is it about?

The objective of this study was to observe the hypocholesterolemic effect of soybean b-conglycinin (7S protein) alone and combined with fenofibrate and rosuvastatin, two hypolipidemic drugs. The results of our study indicate that conglycinin has effects comparable to fenofibrate and rosuvastatin on the control of plasma cholesterol, HDL-C and triacylglycerides, when given to hypercholesterolemic rats, and suggests. that the association of this protein with rosuvastatin alters the action of drug in the homeostasis of cholesterol.

Featured Image